TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,156,000 | -16.4% | 263,827 | -8.0% | 0.05% | -18.3% |
| Q4 2014 | $1,382,000 | +17.8% | 286,801 | 0.0% | 0.06% | +13.2% |
| Q3 2014 | $1,173,000 | -29.7% | 286,801 | 0.0% | 0.05% | -17.2% |
| Q2 2014 | $1,669,000 | -13.5% | 286,801 | -5.0% | 0.06% | -34.7% |
| Q1 2014 | $1,929,000 | -51.1% | 301,801 | -27.3% | 0.10% | -45.9% |
| Q4 2013 | $3,947,000 | – | 415,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 4,644,705 | $19,322,000 | 7.71% |
| First Washington CORP | 185,250 | $771,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 194,200 | $808,000 | 0.10% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 286,801 | $1,173,000 | 0.05% |
| EMERALD ADVISERS, LLC | 175,000 | $728,000 | 0.04% |
| Pine River Capital Management L.P. | 209,900 | $873,000 | 0.01% |
| Alyeska Investment Group, L.P. | 79,196 | $329,000 | 0.01% |
| HighTower Advisors, LLC | 66,514 | $277,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,441 | $6,000 | 0.00% |
| First Eagle Investment Management, LLC | 114,456 | $476,000 | 0.00% |